H-PGDS inhibitors (Taiho)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameH-PGDS inhibitors (Taiho)
Drug Alias Nameprostanoid antagonists (Taiho)hematopoietic prostaglandin D2 synthase inhibitors (Taiho)TAS-204
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstaglandin-H2 D-isomerase inhibitors
TargetsProstaglandin-H2 D-isomerase
Therapy Area/IndicationsInflammationHypersensitivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTaiho Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTaiho Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsInflammationHypersensitivity

Other Information

ATC CodeN/A
Related LinksN/A